Related Experiment Video
Updated: Sep 9, 2025

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
PCV-2 vaccination modifies the cytokine serum profile in wild boar (Sus scrofa) coinfected with tuberculosis and
Rocío Holgado-Martín1, David Risco1, Alfonso Ramos2
1Departamento de Medicina Animal, Área de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria de Cáceres, Universidad de Extremadura, Cáceres, 10003, Spain.
Abstract:
Animal tuberculosis (TB) and porcine circovirus 2 (PCV-2) coinfections have been associated to the development of severe patterns of tuberculous lesions. These coinfections are frequently observed in wild boar, considered the main wild reservoir of TB in Spain. The vaccination of wild boar with a single dose of PCV-2 vaccine has been associated with less severity of lesions. However, the underlying immune mechanisms affecting these animals remain scarcely known. The aim of this study was to determine whether PCV-2 vaccination alters cytokine concentrations in the serum of wild boars naturally coinfected with TB and PCV-2. Serum samples were collected from hunted wild boar in game estates where part of the population had been previously vaccinated against PCV-2. Serum cytokine concentrations were measured using the MILLIPLEX MAP multiplex assay, and the results were analysed using Principal Component Analysis (PCA). The results suggest significant differences in the concentrations of IL-1β, IL-2, IL-10, IL-12, and IL-18 cytokines between PCV-2-vaccinated and non-vaccinated animals, with lower levels observed in the vaccinated group. IL-1β, IL-2, IL-12 and IL-18 are pro-inflammatory cytokines involved in Th1 response. Exacerbated inflammatory responses can result in more severe lesional patterns. Therefore, the reduced levels of these cytokines observed in PCV-2-vaccinated animals could be associated with the presence of less severe tuberculous lesional patterns.
More Related Videos
08:13Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: